Celera Diagnostics to use Luminex' xMAP technology:
This article was originally published in Clinica
Executive Summary
Alameda, California-based Celera Diagnostics, a joint venture between Applied Biosystems and Celera Genomics, is to have worldwide, nonexclusive rights to develop and distribute in vitro diagnostic products based on Luminex' xMAP technology. Under the deal, Austin, Texas-based Luminex will gain royalties, as well as revenue from the sale of instruments and xMAP microspheres. "We believe the addition of Celera Diagnostics' future molecular tests to the growing list of commercial diagnostic assays can significantly expand the capabilities and acceptance of the Luminex xMAP technology," said Randy Marfin, vice-president of business development at Luminex.